CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cansino Biologics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cansino Biologics Inc
West District Biomedical Park, No. 185
South Avenue, West District, Economic
Phone: +86 2258213766p:+86 2258213766 TIANJIN, TNJ  300457  China Ticker: 688185688185
Business Summary
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Chief Executive Officer, General Manager XuefengYu 61 1/13/2009 1/13/2009
Chief Operating Officer, Deputy General Manager, Executive Director ShoubaiChao 62 6/22/2018 5/1/2018
Chief Scientific Officer, Deputy General Manager TaoZhu 51 2/1/2024 1/13/2009
7 additional Officers and Directors records available in full report.

Business Names
Business Name
6185
688185
CJH

General Information
Number of Employees: 1,494 (As of 12/31/2023)
Outstanding Shares: 247,449,899 (As of 12/31/2023)
Shareholders: 22,614
Stock Exchange: SHA
Fax Number: +86 2258213626


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024